Verified active February 2, 2026

Key Highlights

  • UniQuest has a long-standing history of successful commercialisation, dating back to 1984, making it a trusted partner for UQ researchers.
  • The company's notable achievements include the development of the blockbuster cervical cancer vaccine Gardasil®, showcasing its ability to bring groundbreaking research to market.
  • UniQuest has formed over 100 start-up companies based on UQ IP, highlighting its role in fostering innovation and entrepreneurship.
  • The acquisition of Spinifex Pharmaceuticals Inc and Inflazome Ltd in significant university start-up exits demonstrates UniQuest's impact on the commercialisation landscape.
  • UniQuest's strategic location in Brisbane, Queensland, positions it at the heart of Australia's research and innovation ecosystem.

About UniQuest

UniQuest is the commercialisation company of The University of Queensland (UQ). Established in 1984, it partners with UQ researchers to create impact through the commercialisation of UQ intellectual property (IP). With a track record of forming over 100 start-up companies, UniQuest has been instrumental in the development of notable successes such as the cervical cancer vaccine Gardasil®.

UniQuest's notable achievements include the creation of Spinifex Pharmaceuticals Inc and Inflazome Ltd, which were acquired in two of the largest university start-up exits in Australian history. This commercialisation company has positioned UQ as the leader of research commercialisation in Australasia.

UniQuest operates from Brisbane, Queensland, Australia, and employs 139 individuals. As a privately held company, it continues to drive innovation and impact through its strategic partnerships with UQ researchers.

Company Facts

Ownership Private Company
Parent Company The University of Queensland

Connect with UniQuest

Why Contact UniQuest?

B2B professionals would contact UniQuest for its proven track record in commercialising university research, access to cutting-edge intellectual property, and potential for high-impact partnerships. UniQuest offers a unique opportunity to collaborate with a leader in research commercialisation.

Who Should Contact UniQuest for Business?

Sales teams selling research commercialisation services, recruiters seeking roles in innovation and entrepreneurship, and partners offering technology transfer and start-up support should reach out to UniQuest.

Categories

  • commercialisation
  • intellectual property
  • start-up companies
  • research partnerships
  • university IP
  • innovation
  • entrepreneurial support
  • commercial success
  • research impact
  • technology transfer

Frequently Asked Questions

What does UniQuest do?
UniQuest is the commercialisation company of The University of Queensland (UQ). It works in partnership with UQ researchers to create impact through the commercialisation of UQ intellectual property.
How many employees does UniQuest have?
UniQuest has approximately 139 employees.
Where is UniQuest headquartered?
UniQuest is associated with The University of Queensland, which is located in Australia.
What industry is UniQuest in?
UniQuest operates in Research Commercialisation, Intellectual Property, Start-up Support.
When was UniQuest founded?
UniQuest was founded in 1984.
What is the email format at UniQuest?
UniQuest uses the email format f.last@uniquest.com.au.
Is UniQuest still active?
Yes, UniQuest was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to UniQuest?
Research UniQuest's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.

Ready to Sell to UniQuest?

Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.

Discover Similar Companies
Find Decision Makers
Outreach Monitoring

View pricing · FAQs · Contact us

Last verified: February 2, 2026

Backed by startup programs from